High Purity 4-Hydroxythiobenzamide Powder: A Key Intermediate for Pharmaceutical Synthesis
Unlock the potential of advanced pharmaceutical synthesis with our high-purity 4-Hydroxythiobenzamide.
Get a Quote & SampleProduct Core Value

4-Hydroxythiobenzamide Powder
4-Hydroxythiobenzamide (CAS 25984-63-8) is a critical building block in the pharmaceutical industry. Its primary application is as a Febuxostat intermediate, a key component in gout treatment medications. Beyond this, it serves in the synthesis of PPARα agonists aimed at increasing HDLc levels and in the development of potent CDK5 inhibitors for Alzheimer's disease treatment. We offer this essential compound with assured quality and purity for your demanding research and manufacturing needs.
- Explore the synthesis of PPARα agonists used in increasing HDLc levels with 4-Hydroxythiobenzamide.
- Utilize this crucial Febuxostat intermediate for effective gout medication API manufacturing.
- Investigate its role in the synthesis of potent CDK5 inhibitors for Alzheimer's disease treatment.
- Access high-purity 4-Hydroxythiobenzamide for reliable pharmaceutical synthesis and research.
Key Advantages
Exceptional Purity
Ensure your synthesis yields are maximized with our 4-Hydroxythiobenzamide, consistently meeting purity standards of 99% or higher, vital for pharmaceutical intermediate applications.
Versatile Applications
This compound is a cornerstone for producing Febuxostat, and also facilitates research into advanced therapeutics like PPAR agonists and CDK5 inhibitors.
Reliable Supply Chain
Count on a consistent and dependable supply of this pharmaceutical intermediate, backed by extensive manufacturing experience and quality control.
Key Applications
Febuxostat Synthesis
As a primary Febuxostat intermediate, it is indispensable for the production of this important anti-gout medication, supporting better health outcomes.
PPARα Agonist Development
Facilitates the creation of novel compounds aimed at improving cardiovascular health by increasing HDLc levels, leveraging its unique chemical structure.
CDK5 Inhibitor Research
Essential for synthesizing potent inhibitors targeting CDK5, offering potential new avenues for treating neurodegenerative diseases like Alzheimer's.
Custom Pharmaceutical Synthesis
Serves as a valuable building block for custom synthesis projects, enabling the creation of diverse and complex pharmaceutical molecules.